Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.33815211 |
2 | L-phenylalanine catabolic process (GO:0006559) | 7.33815211 |
3 | L-phenylalanine metabolic process (GO:0006558) | 6.99975484 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.99975484 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 6.65228791 |
6 | epoxygenase P450 pathway (GO:0019373) | 6.49353298 |
7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.24879751 |
8 | tryptophan catabolic process (GO:0006569) | 6.04286540 |
9 | indole-containing compound catabolic process (GO:0042436) | 6.04286540 |
10 | indolalkylamine catabolic process (GO:0046218) | 6.04286540 |
11 | omega-hydroxylase P450 pathway (GO:0097267) | 6.00875181 |
12 | kynurenine metabolic process (GO:0070189) | 5.92086111 |
13 | exogenous drug catabolic process (GO:0042738) | 5.78894551 |
14 | bile acid biosynthetic process (GO:0006699) | 5.74206284 |
15 | tryptophan metabolic process (GO:0006568) | 5.69781730 |
16 | urea metabolic process (GO:0019627) | 5.55554578 |
17 | urea cycle (GO:0000050) | 5.55554578 |
18 | glyoxylate metabolic process (GO:0046487) | 5.52133339 |
19 | high-density lipoprotein particle remodeling (GO:0034375) | 5.51590007 |
20 | negative regulation of fibrinolysis (GO:0051918) | 5.48688467 |
21 | regulation of protein activation cascade (GO:2000257) | 5.44142694 |
22 | protein carboxylation (GO:0018214) | 5.42225918 |
23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.42225918 |
24 | alpha-linolenic acid metabolic process (GO:0036109) | 5.40811767 |
25 | regulation of fibrinolysis (GO:0051917) | 5.28012100 |
26 | cysteine metabolic process (GO:0006534) | 5.26426571 |
27 | sulfur amino acid catabolic process (GO:0000098) | 5.19357440 |
28 | complement activation, alternative pathway (GO:0006957) | 5.13162359 |
29 | regulation of complement activation (GO:0030449) | 5.12591488 |
30 | nitrogen cycle metabolic process (GO:0071941) | 5.10226934 |
31 | serine family amino acid catabolic process (GO:0009071) | 4.93849313 |
32 | bile acid metabolic process (GO:0008206) | 4.92918081 |
33 | reverse cholesterol transport (GO:0043691) | 4.81369982 |
34 | aromatic amino acid family metabolic process (GO:0009072) | 4.80995824 |
35 | regulation of cholesterol esterification (GO:0010872) | 4.78185864 |
36 | macromolecular complex remodeling (GO:0034367) | 4.72892296 |
37 | plasma lipoprotein particle remodeling (GO:0034369) | 4.72892296 |
38 | protein-lipid complex remodeling (GO:0034368) | 4.72892296 |
39 | regulation of triglyceride catabolic process (GO:0010896) | 4.69501363 |
40 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.68080130 |
41 | tyrosine metabolic process (GO:0006570) | 4.67143752 |
42 | homocysteine metabolic process (GO:0050667) | 4.62391543 |
43 | triglyceride homeostasis (GO:0070328) | 4.52492008 |
44 | acylglycerol homeostasis (GO:0055090) | 4.52492008 |
45 | plasma lipoprotein particle clearance (GO:0034381) | 4.51272077 |
46 | phospholipid efflux (GO:0033700) | 4.48602062 |
47 | negative regulation of cholesterol transport (GO:0032375) | 4.48571999 |
48 | negative regulation of sterol transport (GO:0032372) | 4.48571999 |
49 | alpha-amino acid catabolic process (GO:1901606) | 4.46600740 |
50 | amino-acid betaine metabolic process (GO:0006577) | 4.40560705 |
51 | lysine metabolic process (GO:0006553) | 4.38722221 |
52 | lysine catabolic process (GO:0006554) | 4.38722221 |
53 | cellular glucuronidation (GO:0052695) | 4.34855381 |
54 | bile acid and bile salt transport (GO:0015721) | 4.28781552 |
55 | indolalkylamine metabolic process (GO:0006586) | 4.26657405 |
56 | fibrinolysis (GO:0042730) | 4.24182911 |
57 | drug metabolic process (GO:0017144) | 4.23737676 |
58 | cellular biogenic amine catabolic process (GO:0042402) | 4.23228747 |
59 | amine catabolic process (GO:0009310) | 4.23228747 |
60 | cholesterol efflux (GO:0033344) | 4.20382459 |
61 | cellular ketone body metabolic process (GO:0046950) | 4.20252688 |
62 | glycine metabolic process (GO:0006544) | 4.20208991 |
63 | negative regulation of protein activation cascade (GO:2000258) | 4.19731175 |
64 | imidazole-containing compound metabolic process (GO:0052803) | 4.19158849 |
65 | aldehyde catabolic process (GO:0046185) | 4.15887763 |
66 | coenzyme catabolic process (GO:0009109) | 4.13006832 |
67 | cellular amino acid catabolic process (GO:0009063) | 4.09710725 |
68 | benzene-containing compound metabolic process (GO:0042537) | 4.08953507 |
69 | blood coagulation, intrinsic pathway (GO:0007597) | 4.07889374 |
70 | ethanol metabolic process (GO:0006067) | 4.07424657 |
71 | glutamate metabolic process (GO:0006536) | 4.07147425 |
72 | serine family amino acid metabolic process (GO:0009069) | 3.99994190 |
73 | low-density lipoprotein particle remodeling (GO:0034374) | 3.98903095 |
74 | plasma lipoprotein particle assembly (GO:0034377) | 3.94252681 |
75 | cellular modified amino acid catabolic process (GO:0042219) | 3.93780371 |
76 | arginine metabolic process (GO:0006525) | 3.93450608 |
77 | response to mercury ion (GO:0046689) | 3.93081641 |
78 | glucuronate metabolic process (GO:0019585) | 3.91947716 |
79 | uronic acid metabolic process (GO:0006063) | 3.91947716 |
80 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.91812398 |
81 | sodium-independent organic anion transport (GO:0043252) | 3.87964680 |
82 | ethanol oxidation (GO:0006069) | 3.86110163 |
83 | drug catabolic process (GO:0042737) | 3.85378898 |
84 | serine family amino acid biosynthetic process (GO:0009070) | 3.84321963 |
85 | cofactor catabolic process (GO:0051187) | 3.77609712 |
86 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.76789028 |
87 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.76789028 |
88 | protein activation cascade (GO:0072376) | 3.76697177 |
89 | oxidative demethylation (GO:0070989) | 3.72119096 |
90 | complement activation, classical pathway (GO:0006958) | 3.70532466 |
91 | complement activation (GO:0006956) | 3.69756976 |
92 | cholesterol homeostasis (GO:0042632) | 3.68238394 |
93 | phospholipid homeostasis (GO:0055091) | 3.67983685 |
94 | positive regulation of lipid catabolic process (GO:0050996) | 3.67902085 |
95 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.66217664 |
96 | * gamma-aminobutyric acid transport (GO:0015812) | 3.65238344 |
97 | sterol homeostasis (GO:0055092) | 3.62707940 |
98 | ketone body metabolic process (GO:1902224) | 3.62433769 |
99 | plasma lipoprotein particle organization (GO:0071827) | 3.61783448 |
100 | negative regulation of lipase activity (GO:0060192) | 3.59104861 |
101 | opsonization (GO:0008228) | 3.58064689 |
102 | organic acid catabolic process (GO:0016054) | 3.57575107 |
103 | carboxylic acid catabolic process (GO:0046395) | 3.57575107 |
104 | protein-lipid complex assembly (GO:0065005) | 3.54740229 |
105 | NAD biosynthetic process (GO:0009435) | 3.53609174 |
106 | regulation of cholesterol homeostasis (GO:2000188) | 3.51709655 |
107 | regulation of bile acid biosynthetic process (GO:0070857) | 3.51608718 |
108 | acute-phase response (GO:0006953) | 3.51454718 |
109 | phenylpropanoid metabolic process (GO:0009698) | 3.50594933 |
110 | regulation of humoral immune response (GO:0002920) | 3.50386673 |
111 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.49560168 |
112 | regulation of plasminogen activation (GO:0010755) | 3.47546145 |
113 | S-adenosylmethionine metabolic process (GO:0046500) | 3.31558858 |
114 | negative regulation of blood coagulation (GO:0030195) | 3.30613947 |
115 | negative regulation of hemostasis (GO:1900047) | 3.30613947 |
116 | alkaloid metabolic process (GO:0009820) | 3.28446872 |
117 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.15695884 |
118 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.15695884 |
119 | steroid catabolic process (GO:0006706) | 3.07025087 |
120 | negative regulation of complement activation (GO:0045916) | 3.02668615 |
121 | positive regulation of blood coagulation (GO:0030194) | 3.02666740 |
122 | positive regulation of hemostasis (GO:1900048) | 3.02666740 |
123 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.98788499 |
124 | negative regulation of coagulation (GO:0050819) | 2.98619977 |
125 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.93611013 |
126 | positive regulation of coagulation (GO:0050820) | 2.92660046 |
127 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.89838045 |
128 | negative regulation of wound healing (GO:0061045) | 2.81719021 |
129 | cytolysis (GO:0019835) | 2.78206354 |
130 | indole-containing compound metabolic process (GO:0042430) | 2.77885657 |
131 | acute inflammatory response (GO:0002526) | 2.73302790 |
132 | regulation of acute inflammatory response (GO:0002673) | 2.72874691 |
133 | heme transport (GO:0015886) | 2.72422095 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.15991013 |
2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.98577527 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.89302552 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.33068832 |
5 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.08231788 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.00836690 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.69873062 |
8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.89515789 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.86090511 |
10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.22390035 |
11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.5797999 |
12 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.96122732 |
13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.95284676 |
14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.89537514 |
15 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.89264684 |
16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.63659410 |
17 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.58098769 |
18 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.57714681 |
19 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.51130520 |
20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.49419768 |
21 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.46254318 |
22 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.45222983 |
23 | GATA1_22025678_ChIP-Seq_K562_Human | 1.44718041 |
24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.39667377 |
25 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.39363972 |
26 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.37809711 |
27 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37280064 |
28 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.33187989 |
29 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.20501307 |
30 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.20366162 |
31 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.17835719 |
32 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.16348610 |
33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.15579367 |
34 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.14233503 |
35 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.11672970 |
36 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.11611063 |
37 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07449135 |
38 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.06065781 |
39 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.05452065 |
40 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05115968 |
41 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.04661114 |
42 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.02189723 |
43 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01431718 |
44 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.00253322 |
45 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.96676474 |
46 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96442816 |
47 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.95105678 |
48 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.94263097 |
49 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.93983666 |
50 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.92809512 |
51 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.92045807 |
52 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.90372418 |
53 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.89991170 |
54 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88412714 |
55 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.88301203 |
56 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.87538142 |
57 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.87310204 |
58 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.86992296 |
59 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.85750197 |
60 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.84690074 |
61 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.84411014 |
62 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.82759831 |
63 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.81384655 |
64 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.81288654 |
65 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.81097898 |
66 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.80377951 |
67 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.79753227 |
68 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.79753227 |
69 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79544130 |
70 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.78924459 |
71 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.78583270 |
72 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.78092092 |
73 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.77739576 |
74 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.77454450 |
75 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.77403708 |
76 | SPI1_23127762_ChIP-Seq_K562_Human | 0.76220939 |
77 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.76078380 |
78 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.75602845 |
79 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.75524210 |
80 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.74700724 |
81 | SA1_27219007_Chip-Seq_Bcells_Human | 0.74586411 |
82 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.74063097 |
83 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.73631237 |
84 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.73449984 |
85 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.73345811 |
86 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.72711454 |
87 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.72621369 |
88 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72443441 |
89 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.70956742 |
90 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.70801917 |
91 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.70132445 |
92 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.69971123 |
93 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.69759994 |
94 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.69738336 |
95 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.69637273 |
96 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.69520174 |
97 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.69196891 |
98 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.69035576 |
99 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.68941860 |
100 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.68393180 |
101 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.67179480 |
102 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66761213 |
103 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.66609254 |
104 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.66609254 |
105 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.66210232 |
106 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.65825348 |
107 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.64970465 |
108 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.64679031 |
109 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.63642598 |
110 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.62997796 |
111 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.62709755 |
112 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.60442227 |
113 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60115798 |
114 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.59067670 |
115 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.57833377 |
116 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57181643 |
117 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.56646722 |
118 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.55118010 |
119 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.53360502 |
120 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.53153777 |
121 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.52354925 |
122 | AR_20517297_ChIP-Seq_VCAP_Human | 0.51795484 |
123 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.51709948 |
124 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.51538793 |
125 | GATA1_19941826_ChIP-Seq_K562_Human | 0.51040414 |
126 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.50869956 |
127 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.49677813 |
128 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.49652581 |
129 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.49469393 |
130 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.48369903 |
131 | * EGR1_19032775_ChIP-ChIP_M12_Human | 0.48262437 |
132 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.47445298 |
133 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.47214612 |
134 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.47163718 |
135 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.46661830 |
136 | CBP_21632823_ChIP-Seq_H3396_Human | 0.46434934 |
137 | GATA2_19941826_ChIP-Seq_K562_Human | 0.46013599 |
138 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.45950468 |
139 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.45596646 |
140 | * ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.45489843 |
141 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.44842531 |
142 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.44045955 |
143 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.43976555 |
144 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.43288653 |
145 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.42859328 |
146 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.42296151 |
147 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.41823472 |
148 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.41611187 |
149 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.40748378 |
150 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.40008518 |
151 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.39967197 |
152 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.39935408 |
153 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.39361725 |
154 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.39293354 |
155 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.38488072 |
156 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.37947712 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.06618439 |
2 | MP0005360_urolithiasis | 7.34598865 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.19908223 |
4 | MP0005365_abnormal_bile_salt | 5.88812544 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.01391389 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.15527500 |
7 | MP0003252_abnormal_bile_duct | 3.73888333 |
8 | MP0010329_abnormal_lipoprotein_level | 3.52777364 |
9 | MP0009840_abnormal_foam_cell | 3.52291725 |
10 | MP0003195_calcinosis | 3.10258765 |
11 | MP0005083_abnormal_biliary_tract | 3.04827720 |
12 | MP0005332_abnormal_amino_acid | 2.68891593 |
13 | MP0003191_abnormal_cellular_cholesterol | 2.45786046 |
14 | MP0001666_abnormal_nutrient_absorption | 2.45590815 |
15 | MP0000609_abnormal_liver_physiology | 2.14446049 |
16 | MP0004019_abnormal_vitamin_homeostasis | 2.04637581 |
17 | MP0002118_abnormal_lipid_homeostasis | 2.04540910 |
18 | MP0002138_abnormal_hepatobiliary_system | 1.90922959 |
19 | MP0005319_abnormal_enzyme/_coenzyme | 1.86267455 |
20 | MP0003868_abnormal_feces_composition | 1.75660039 |
21 | MP0003879_abnormal_hair_cell | 1.72649469 |
22 | MP0003303_peritoneal_inflammation | 1.70656060 |
23 | MP0001764_abnormal_homeostasis | 1.62736867 |
24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.58471739 |
25 | MP0009697_abnormal_copulation | 1.57415379 |
26 | MP0005451_abnormal_body_composition | 1.48192613 |
27 | MP0003186_abnormal_redox_activity | 1.40913970 |
28 | MP0004043_abnormal_pH_regulation | 1.39948783 |
29 | MP0003011_delayed_dark_adaptation | 1.39671192 |
30 | MP0003656_abnormal_erythrocyte_physiolo | 1.39201489 |
31 | MP0000604_amyloidosis | 1.33563856 |
32 | MP0001501_abnormal_sleep_pattern | 1.33000972 |
33 | MP0000920_abnormal_myelination | 1.28794764 |
34 | MP0003183_abnormal_peptide_metabolism | 1.28441352 |
35 | MP0002148_abnormal_hypersensitivity_rea | 1.28331203 |
36 | MP0009764_decreased_sensitivity_to | 1.27302150 |
37 | MP0009643_abnormal_urine_homeostasis | 1.27042904 |
38 | MP0004859_abnormal_synaptic_plasticity | 1.22530563 |
39 | MP0009745_abnormal_behavioral_response | 1.21162792 |
40 | MP0002064_seizures | 1.20656569 |
41 | MP0001835_abnormal_antigen_presentation | 1.20175495 |
42 | MP0003705_abnormal_hypodermis_morpholog | 1.19312723 |
43 | MP0000598_abnormal_liver_morphology | 1.18496682 |
44 | MP0002254_reproductive_system_inflammat | 1.10445176 |
45 | MP0002132_abnormal_respiratory_system | 1.09492592 |
46 | MP0009763_increased_sensitivity_to | 1.09350304 |
47 | MP0008469_abnormal_protein_level | 1.06586049 |
48 | MP0005671_abnormal_response_to | 1.02772761 |
49 | MP0005647_abnormal_sex_gland | 1.02303260 |
50 | MP0003633_abnormal_nervous_system | 1.01934651 |
51 | MP0000685_abnormal_immune_system | 0.98805685 |
52 | MP0001986_abnormal_taste_sensitivity | 0.97959660 |
53 | MP0010386_abnormal_urinary_bladder | 0.95906334 |
54 | MP0005000_abnormal_immune_tolerance | 0.94523511 |
55 | MP0005636_abnormal_mineral_homeostasis | 0.94180553 |
56 | MP0001486_abnormal_startle_reflex | 0.91918860 |
57 | MP0005387_immune_system_phenotype | 0.90760475 |
58 | MP0001790_abnormal_immune_system | 0.90760475 |
59 | MP0005646_abnormal_pituitary_gland | 0.90422931 |
60 | MP0010368_abnormal_lymphatic_system | 0.88847316 |
61 | MP0009642_abnormal_blood_homeostasis | 0.88609526 |
62 | MP0003436_decreased_susceptibility_to | 0.87281028 |
63 | MP0005376_homeostasis/metabolism_phenot | 0.85377692 |
64 | MP0005408_hypopigmentation | 0.84631559 |
65 | MP0003631_nervous_system_phenotype | 0.83692952 |
66 | MP0003880_abnormal_central_pattern | 0.82269224 |
67 | MP0002063_abnormal_learning/memory/cond | 0.80951143 |
68 | MP0001800_abnormal_humoral_immune | 0.80917862 |
69 | MP0003635_abnormal_synaptic_transmissio | 0.79755014 |
70 | MP0002723_abnormal_immune_serum | 0.79681897 |
71 | MP0009765_abnormal_xenobiotic_induced | 0.79352713 |
72 | MP0005464_abnormal_platelet_physiology | 0.77317249 |
73 | MP0002572_abnormal_emotion/affect_behav | 0.75524493 |
74 | MP0004270_analgesia | 0.75148899 |
75 | MP0005670_abnormal_white_adipose | 0.74991189 |
76 | MP0002272_abnormal_nervous_system | 0.74905689 |
77 | MP0003690_abnormal_glial_cell | 0.74761100 |
78 | MP0003632_abnormal_nervous_system | 0.72541856 |
79 | MP0006082_CNS_inflammation | 0.72367592 |
80 | MP0002078_abnormal_glucose_homeostasis | 0.72000241 |
81 | MP0005058_abnormal_lysosome_morphology | 0.71755691 |
82 | MP0006036_abnormal_mitochondrial_physio | 0.71617586 |
83 | MP0008569_lethality_at_weaning | 0.70653227 |
84 | MP0003724_increased_susceptibility_to | 0.69032433 |
85 | MP0002971_abnormal_brown_adipose | 0.68821994 |
86 | MP0004130_abnormal_muscle_cell | 0.67508924 |
87 | MP0002452_abnormal_antigen_presenting | 0.67410893 |
88 | MP0005535_abnormal_body_temperature | 0.67157707 |
89 | MP0001756_abnormal_urination | 0.66313999 |
90 | MP0005084_abnormal_gallbladder_morpholo | 0.65922073 |
91 | MP0001440_abnormal_grooming_behavior | 0.65131504 |
92 | MP0002876_abnormal_thyroid_physiology | 0.65063932 |
93 | MP0005423_abnormal_somatic_nervous | 0.64964693 |
94 | MP0005334_abnormal_fat_pad | 0.64577945 |
95 | MP0009046_muscle_twitch | 0.63964772 |
96 | MP0005266_abnormal_metabolism | 0.63554421 |
97 | MP0002837_dystrophic_cardiac_calcinosis | 0.61525630 |
98 | MP0003075_altered_response_to | 0.60581042 |
99 | MP0005220_abnormal_exocrine_pancreas | 0.59777303 |
100 | MP0000639_abnormal_adrenal_gland | 0.59456017 |
101 | MP0005397_hematopoietic_system_phenotyp | 0.58687231 |
102 | MP0001661_extended_life_span | 0.57938507 |
103 | MP0003329_amyloid_beta_deposits | 0.57742510 |
104 | MP0009053_abnormal_anal_canal | 0.55492733 |
105 | MP0002136_abnormal_kidney_physiology | 0.54916466 |
106 | MP0005166_decreased_susceptibility_to | 0.53983878 |
107 | MP0009785_altered_susceptibility_to | 0.53524924 |
108 | MP0004782_abnormal_surfactant_physiolog | 0.51008509 |
109 | MP0005164_abnormal_response_to | 0.50473915 |
110 | MP0008873_increased_physiological_sensi | 0.50047715 |
111 | MP0005448_abnormal_energy_balance | 0.49869935 |
112 | MP0003638_abnormal_response/metabolism_ | 0.49215010 |
113 | MP0001845_abnormal_inflammatory_respons | 0.47674633 |
114 | MP0005395_other_phenotype | 0.46579572 |
115 | MP0005167_abnormal_blood-brain_barrier | 0.46101600 |
116 | MP0002419_abnormal_innate_immunity | 0.45995568 |
117 | MP0006035_abnormal_mitochondrial_morpho | 0.45856614 |
118 | MP0008874_decreased_physiological_sensi | 0.45652827 |
119 | MP0000249_abnormal_blood_vessel | 0.45532229 |
120 | MP0004883_abnormal_blood_vessel | 0.43461133 |
121 | MP0001853_heart_inflammation | 0.42251227 |
122 | MP0001533_abnormal_skeleton_physiology | 0.40040706 |
123 | MP0003718_maternal_effect | 0.39316645 |
124 | MP0005248_abnormal_Harderian_gland | 0.37065856 |
125 | MP0005025_abnormal_response_to | 0.36949574 |
126 | MP0003953_abnormal_hormone_level | 0.36504404 |
127 | MP0005666_abnormal_adipose_tissue | 0.34973069 |
128 | MP0001243_abnormal_dermal_layer | 0.34913068 |
129 | MP0002090_abnormal_vision | 0.33569603 |
130 | MP0009115_abnormal_fat_cell | 0.33046128 |
131 | MP0002168_other_aberrant_phenotype | 0.32688812 |
132 | MP0003172_abnormal_lysosome_physiology | 0.31716965 |
133 | MP0002928_abnormal_bile_duct | 0.31566857 |
134 | MP0004947_skin_inflammation | 0.30945458 |
135 | MP0000230_abnormal_systemic_arterial | 0.29776395 |
136 | MP0001542_abnormal_bone_strength | 0.28769378 |
137 | MP0005023_abnormal_wound_healing | 0.28340896 |
138 | MP0008872_abnormal_physiological_respon | 0.27547255 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 7.30203800 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.23301050 |
3 | Intrahepatic cholestasis (HP:0001406) | 7.10392039 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.51505465 |
5 | Prolonged partial thromboplastin time (HP:0003645) | 6.46520714 |
6 | Hypobetalipoproteinemia (HP:0003563) | 6.22890643 |
7 | Xanthomatosis (HP:0000991) | 6.22367185 |
8 | Hyperlipoproteinemia (HP:0010980) | 5.54561955 |
9 | Complement deficiency (HP:0004431) | 5.09127481 |
10 | Joint hemorrhage (HP:0005261) | 4.89975360 |
11 | Hypolipoproteinemia (HP:0010981) | 4.74542938 |
12 | Abnormality of the common coagulation pathway (HP:0010990) | 4.51840158 |
13 | Hyperammonemia (HP:0001987) | 4.39964019 |
14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.32445653 |
15 | Epidermoid cyst (HP:0200040) | 4.30163576 |
16 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.25422994 |
17 | Hypoalphalipoproteinemia (HP:0003233) | 4.22674394 |
18 | Abnormality of methionine metabolism (HP:0010901) | 4.20770215 |
19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.18038526 |
20 | Hyperglycinemia (HP:0002154) | 4.09109698 |
21 | Fat malabsorption (HP:0002630) | 4.02143826 |
22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.00670079 |
23 | Ketosis (HP:0001946) | 3.99108960 |
24 | Abnormality of the intrinsic pathway (HP:0010989) | 3.80188973 |
25 | Abnormality of complement system (HP:0005339) | 3.77008824 |
26 | Conjugated hyperbilirubinemia (HP:0002908) | 3.69908918 |
27 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.69753805 |
28 | Hyperglycinuria (HP:0003108) | 3.64407736 |
29 | Hypoglycemic coma (HP:0001325) | 3.64046153 |
30 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.63455588 |
31 | Abnormality of glycine metabolism (HP:0010895) | 3.63455588 |
32 | Increased circulating renin level (HP:0000848) | 3.61426865 |
33 | Hypercholesterolemia (HP:0003124) | 3.57814903 |
34 | Systemic lupus erythematosus (HP:0002725) | 3.44894215 |
35 | Increased serum ferritin (HP:0003281) | 3.33725159 |
36 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.28181018 |
37 | Hyperbilirubinemia (HP:0002904) | 3.25248791 |
38 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.22292962 |
39 | Metabolic alkalosis (HP:0200114) | 3.21960897 |
40 | Myocardial infarction (HP:0001658) | 3.17957469 |
41 | Abnormality of macrophages (HP:0004311) | 3.14112512 |
42 | Steatorrhea (HP:0002570) | 3.06164501 |
43 | Hypokalemic alkalosis (HP:0001949) | 3.05582392 |
44 | Abnormality of nucleobase metabolism (HP:0010932) | 3.03346365 |
45 | Spontaneous abortion (HP:0005268) | 2.94905407 |
46 | Delayed CNS myelination (HP:0002188) | 2.93288797 |
47 | Hepatocellular carcinoma (HP:0001402) | 2.93217663 |
48 | Abnormality of serum amino acid levels (HP:0003112) | 2.87508765 |
49 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.85428911 |
50 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.76219771 |
51 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.76219771 |
52 | Abnormality of glycolipid metabolism (HP:0010969) | 2.76219771 |
53 | Ketoacidosis (HP:0001993) | 2.72542144 |
54 | Skin nodule (HP:0200036) | 2.70737929 |
55 | Abnormality of purine metabolism (HP:0004352) | 2.70142645 |
56 | Vascular calcification (HP:0004934) | 2.69006167 |
57 | Optic neuritis (HP:0100653) | 2.63419314 |
58 | Retrobulbar optic neuritis (HP:0100654) | 2.63419314 |
59 | Hypochromic microcytic anemia (HP:0004840) | 2.63253144 |
60 | Metabolic acidosis (HP:0001942) | 2.60841427 |
61 | Purpura (HP:0000979) | 2.57495532 |
62 | Hypomagnesemia (HP:0002917) | 2.57152865 |
63 | Glomerulonephritis (HP:0000099) | 2.55941868 |
64 | Gingival bleeding (HP:0000225) | 2.55155889 |
65 | Mitral stenosis (HP:0001718) | 2.54591855 |
66 | Orchitis (HP:0100796) | 2.51763420 |
67 | Gastrointestinal infarctions (HP:0005244) | 2.44008636 |
68 | Spastic diplegia (HP:0001264) | 2.42456607 |
69 | Lethargy (HP:0001254) | 2.42039309 |
70 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.39390882 |
71 | Dicarboxylic aciduria (HP:0003215) | 2.39390882 |
72 | Amyloidosis (HP:0011034) | 2.39343280 |
73 | Cardiovascular calcification (HP:0011915) | 2.38579983 |
74 | Abnormal gallbladder morphology (HP:0012437) | 2.37995053 |
75 | Myositis (HP:0100614) | 2.35973903 |
76 | Acanthocytosis (HP:0001927) | 2.35001721 |
77 | Gangrene (HP:0100758) | 2.32621667 |
78 | Esophageal varix (HP:0002040) | 2.31482437 |
79 | Menorrhagia (HP:0000132) | 2.31101165 |
80 | Cholelithiasis (HP:0001081) | 2.30651846 |
81 | Hypoglycemic seizures (HP:0002173) | 2.29553078 |
82 | Irritability (HP:0000737) | 2.27949414 |
83 | Gout (HP:0001997) | 2.27860172 |
84 | Abnormal urine output (HP:0012590) | 2.26909540 |
85 | Recurrent abscess formation (HP:0002722) | 2.26742287 |
86 | Neonatal onset (HP:0003623) | 2.25965088 |
87 | Cholecystitis (HP:0001082) | 2.21938040 |
88 | Abnormal gallbladder physiology (HP:0012438) | 2.21938040 |
89 | Cerebral edema (HP:0002181) | 2.20581022 |
90 | Hydroxyprolinuria (HP:0003080) | 2.20155718 |
91 | Abnormality of proline metabolism (HP:0010907) | 2.20155718 |
92 | Sensorimotor neuropathy (HP:0007141) | 2.19892775 |
93 | Malnutrition (HP:0004395) | 2.18895205 |
94 | Myokymia (HP:0002411) | 2.13303658 |
95 | Pancreatitis (HP:0001733) | 2.12764189 |
96 | Thrombophlebitis (HP:0004418) | 2.11931779 |
97 | Polyuria (HP:0000103) | 2.11563241 |
98 | Increased cerebral lipofuscin (HP:0011813) | 2.10280247 |
99 | Neurofibrillary tangles (HP:0002185) | 2.07359186 |
100 | Hemorrhage of the eye (HP:0011885) | 2.04853162 |
101 | Opisthotonus (HP:0002179) | 2.03838818 |
102 | Vomiting (HP:0002013) | 2.03563803 |
103 | Abnormality of binocular vision (HP:0011514) | 2.02401461 |
104 | Diplopia (HP:0000651) | 2.02401461 |
105 | Enlarged kidneys (HP:0000105) | 2.01007068 |
106 | Dysostosis multiplex (HP:0000943) | 2.00872656 |
107 | Abnormality of iron homeostasis (HP:0011031) | 2.00720346 |
108 | Abnormality of magnesium homeostasis (HP:0004921) | 2.00555231 |
109 | Fair hair (HP:0002286) | 1.98821261 |
110 | Abnormal cartilage morphology (HP:0002763) | 1.98372980 |
111 | Generalized aminoaciduria (HP:0002909) | 1.97320173 |
112 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.97262099 |
113 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.97262099 |
114 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.97262099 |
115 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.96009975 |
116 | Brushfield spots (HP:0001088) | 1.95583329 |
117 | Vacuolated lymphocytes (HP:0001922) | 1.93718047 |
118 | Mucopolysacchariduria (HP:0008155) | 1.92708518 |
119 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.92708518 |
120 | Joint swelling (HP:0001386) | 1.92294185 |
121 | Abnormality of renal excretion (HP:0011036) | 1.92029035 |
122 | Abnormality of the gallbladder (HP:0005264) | 1.90617188 |
123 | Nephritis (HP:0000123) | 1.90227397 |
124 | Late onset (HP:0003584) | 1.89328353 |
125 | Alkalosis (HP:0001948) | 1.88703731 |
126 | Poikilocytosis (HP:0004447) | 1.87893084 |
127 | Recurrent bacterial skin infections (HP:0005406) | 1.87258149 |
128 | Abnormality of the periventricular white matter (HP:0002518) | 1.85806353 |
129 | Anorexia (HP:0002039) | 1.84142233 |
130 | Hyperactive renin-angiotensin system (HP:0000841) | 1.83874310 |
131 | Hypophosphatemic rickets (HP:0004912) | 1.83533112 |
132 | Eczematoid dermatitis (HP:0000976) | 1.83135125 |
133 | Facial shape deformation (HP:0011334) | 1.83068948 |
134 | Potter facies (HP:0002009) | 1.83068948 |
135 | Rickets (HP:0002748) | 1.82666235 |
136 | Hyperaldosteronism (HP:0000859) | 1.82244207 |
137 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.81283999 |
138 | Hyperphosphaturia (HP:0003109) | 1.80497933 |
139 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.77369153 |
140 | Osteomalacia (HP:0002749) | 1.75767785 |
141 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.75435002 |
142 | Nausea (HP:0002018) | 1.74579609 |
143 | Elevated hepatic transaminases (HP:0002910) | 1.74226404 |
144 | Protuberant abdomen (HP:0001538) | 1.73408825 |
145 | Stomatitis (HP:0010280) | 1.73350513 |
146 | Pulmonary embolism (HP:0002204) | 1.73248857 |
147 | Tetany (HP:0001281) | 1.72581103 |
148 | Reticulocytosis (HP:0001923) | 1.72420950 |
149 | Epistaxis (HP:0000421) | 1.69851702 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 6.38409129 |
2 | ERN1 | 4.80876438 |
3 | FGFR4 | 4.29426187 |
4 | SIK1 | 4.28885243 |
5 | WNK3 | 3.13378715 |
6 | TAOK3 | 2.89217546 |
7 | RIPK4 | 2.71482886 |
8 | OXSR1 | 2.68718999 |
9 | NTRK3 | 2.66071688 |
10 | ERBB4 | 2.56882273 |
11 | MST1R | 2.47783301 |
12 | PKN2 | 2.35661667 |
13 | INSRR | 2.34881042 |
14 | EPHA4 | 2.11636122 |
15 | TYK2 | 2.06958087 |
16 | MAP3K12 | 2.02862157 |
17 | TRIB3 | 1.86902615 |
18 | MAP2K4 | 1.85330843 |
19 | TBK1 | 1.82489299 |
20 | ABL2 | 1.76973367 |
21 | FLT3 | 1.73409516 |
22 | GRK7 | 1.70427649 |
23 | PIK3CG | 1.67736044 |
24 | MAP3K14 | 1.66771430 |
25 | PAK6 | 1.65496513 |
26 | ADRBK2 | 1.60717678 |
27 | MAPK11 | 1.59472369 |
28 | NEK9 | 1.56369551 |
29 | TNK2 | 1.48609302 |
30 | PTK6 | 1.47070965 |
31 | CAMKK1 | 1.46656296 |
32 | LATS1 | 1.42447641 |
33 | MAP3K3 | 1.39210431 |
34 | PBK | 1.37065062 |
35 | IRAK3 | 1.34130613 |
36 | DAPK2 | 1.33587264 |
37 | FGR | 1.32880692 |
38 | KDR | 1.28571850 |
39 | MAP2K3 | 1.28113667 |
40 | SGK494 | 1.26840948 |
41 | SGK223 | 1.26840948 |
42 | JAK1 | 1.22803473 |
43 | JAK2 | 1.22299347 |
44 | MATK | 1.21488283 |
45 | NTRK2 | 1.20335874 |
46 | CAMKK2 | 1.16401128 |
47 | FES | 1.14460145 |
48 | TXK | 1.08166363 |
49 | UHMK1 | 1.06181095 |
50 | IKBKE | 1.02469284 |
51 | SYK | 1.01927631 |
52 | MAP3K7 | 1.01594293 |
53 | FGFR2 | 1.01121763 |
54 | MAPK4 | 0.96846304 |
55 | BMX | 0.96560389 |
56 | MAPK13 | 0.96115266 |
57 | EPHB1 | 0.95835442 |
58 | MAP3K11 | 0.95743115 |
59 | CSK | 0.95171176 |
60 | STK38L | 0.94355769 |
61 | STK38 | 0.93500775 |
62 | GRK6 | 0.89951761 |
63 | FRK | 0.89824789 |
64 | BLK | 0.89689982 |
65 | PRKAA2 | 0.89068976 |
66 | MAPK12 | 0.87952888 |
67 | BMPR2 | 0.87435110 |
68 | STK11 | 0.87232162 |
69 | MET | 0.86537472 |
70 | PRKCZ | 0.85542952 |
71 | MAP4K2 | 0.84449587 |
72 | ERBB2 | 0.82834222 |
73 | PRPF4B | 0.80941876 |
74 | KSR2 | 0.80402493 |
75 | PINK1 | 0.78345158 |
76 | MAP3K2 | 0.76474288 |
77 | MAP3K13 | 0.75301241 |
78 | PAK3 | 0.74855778 |
79 | PDPK1 | 0.74049731 |
80 | MAP3K10 | 0.73743058 |
81 | CDK6 | 0.73584111 |
82 | DAPK1 | 0.72085780 |
83 | DDR2 | 0.70889246 |
84 | PRKACG | 0.70085308 |
85 | SGK1 | 0.69190594 |
86 | TGFBR2 | 0.68454109 |
87 | EPHA3 | 0.66513887 |
88 | IRAK4 | 0.66124806 |
89 | CSF1R | 0.65892602 |
90 | KIT | 0.64945818 |
91 | MARK1 | 0.64900465 |
92 | GSK3A | 0.62069060 |
93 | DYRK1B | 0.59226818 |
94 | TYRO3 | 0.58883726 |
95 | TIE1 | 0.58773822 |
96 | MINK1 | 0.58161180 |
97 | TAOK2 | 0.57883629 |
98 | SGK3 | 0.56816324 |
99 | MAP3K5 | 0.55847386 |
100 | PRKG1 | 0.55430393 |
101 | WNK4 | 0.54734857 |
102 | CDC42BPA | 0.54723260 |
103 | GRK5 | 0.54132073 |
104 | CDK5 | 0.54021770 |
105 | LCK | 0.53811052 |
106 | YES1 | 0.53717484 |
107 | IKBKB | 0.53522482 |
108 | FGFR3 | 0.51979798 |
109 | IGF1R | 0.51630295 |
110 | ARAF | 0.51562306 |
111 | MAPK7 | 0.51540668 |
112 | AKT2 | 0.51339900 |
113 | CAMK2G | 0.51009528 |
114 | CAMK1 | 0.50025378 |
115 | PRKCQ | 0.49803416 |
116 | CAMK1D | 0.49415338 |
117 | DYRK1A | 0.49258548 |
118 | PRKAA1 | 0.48967797 |
119 | PRKD3 | 0.48717132 |
120 | PRKCA | 0.48209922 |
121 | PDK1 | 0.46711994 |
122 | ZAP70 | 0.46119480 |
123 | EGFR | 0.46105715 |
124 | MAP4K1 | 0.45358642 |
125 | PTK2 | 0.44191760 |
126 | MAP2K6 | 0.41318083 |
127 | NME2 | 0.41177657 |
128 | MAP2K1 | 0.40414400 |
129 | GRK1 | 0.40343226 |
130 | MAPK15 | 0.39883182 |
131 | MAP2K2 | 0.39533461 |
132 | CSNK1G1 | 0.36174646 |
133 | CHUK | 0.35403258 |
134 | RIPK1 | 0.35041785 |
135 | STK3 | 0.34990275 |
136 | SGK2 | 0.34841241 |
137 | RET | 0.34558811 |
138 | ABL1 | 0.32850224 |
139 | JAK3 | 0.31568665 |
140 | MAP3K1 | 0.31460004 |
141 | PKN1 | 0.29952166 |
142 | LYN | 0.29661155 |
143 | CDK4 | 0.29245274 |
144 | PRKCD | 0.27766399 |
145 | FGFR1 | 0.25770166 |
146 | PRKG2 | 0.25394542 |
147 | PDK2 | 0.24229046 |
148 | IRAK2 | 0.24076102 |
149 | PRKCG | 0.23741930 |
150 | MTOR | 0.23733224 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.47808672 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.55976685 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.42993289 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.42887945 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.08941367 |
6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.92764278 |
7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70975038 |
8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.63774995 |
9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.52012152 |
10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.47692031 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.39629856 |
12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.36793788 |
13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.26988175 |
14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.13728228 |
15 | Peroxisome_Homo sapiens_hsa04146 | 2.04712743 |
16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.03085245 |
17 | Histidine metabolism_Homo sapiens_hsa00340 | 2.02227196 |
18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.00310695 |
19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.00286375 |
20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.99322584 |
21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.95069374 |
22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.90748931 |
23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.84762630 |
24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.79171064 |
25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.78819291 |
26 | Retinol metabolism_Homo sapiens_hsa00830 | 1.72244145 |
27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.70856823 |
28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.69504555 |
29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.66229462 |
30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.59434277 |
31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.56842982 |
32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.55752486 |
33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.47031828 |
34 | Bile secretion_Homo sapiens_hsa04976 | 1.46422341 |
35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.46043456 |
36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.41454043 |
37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.38534237 |
38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.34681890 |
39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.32111997 |
40 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.27098777 |
41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.23943540 |
42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.23803889 |
43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.23239345 |
44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.16906422 |
45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16626857 |
46 | ABC transporters_Homo sapiens_hsa02010 | 1.15174315 |
47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.13804836 |
48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.06565391 |
49 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.03423602 |
50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.01606258 |
51 | Sulfur relay system_Homo sapiens_hsa04122 | 0.93828601 |
52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.92552074 |
53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.91314556 |
54 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89135997 |
55 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.86377237 |
56 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.85874494 |
57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.85377631 |
58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82114185 |
59 | Allograft rejection_Homo sapiens_hsa05330 | 0.79043589 |
60 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.78900300 |
61 | Lysine degradation_Homo sapiens_hsa00310 | 0.73547316 |
62 | Other glycan degradation_Homo sapiens_hsa00511 | 0.71419631 |
63 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.69695956 |
64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.68670943 |
65 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.65340256 |
66 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63060649 |
67 | GABAergic synapse_Homo sapiens_hsa04727 | 0.60328813 |
68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59480180 |
69 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.58760131 |
70 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.56686492 |
71 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.56678245 |
72 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.55913739 |
73 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.55644282 |
74 | Leishmaniasis_Homo sapiens_hsa05140 | 0.54247445 |
75 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48152430 |
76 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.46736873 |
77 | Mineral absorption_Homo sapiens_hsa04978 | 0.44910770 |
78 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44039280 |
79 | Prion diseases_Homo sapiens_hsa05020 | 0.42331727 |
80 | Morphine addiction_Homo sapiens_hsa05032 | 0.36800164 |
81 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.36065516 |
82 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.34393125 |
83 | Tuberculosis_Homo sapiens_hsa05152 | 0.34329228 |
84 | Asthma_Homo sapiens_hsa05310 | 0.33830508 |
85 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.33249975 |
86 | Nicotine addiction_Homo sapiens_hsa05033 | 0.32631185 |
87 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.32572705 |
88 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.31951698 |
89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.29132810 |
90 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.28510717 |
91 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28476790 |
92 | Phagosome_Homo sapiens_hsa04145 | 0.26293867 |
93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24254711 |
94 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.23996160 |
95 | Insulin resistance_Homo sapiens_hsa04931 | 0.22205462 |
96 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.21408481 |
97 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.19356835 |
98 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.15523105 |
99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.15040976 |
100 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.14740165 |
101 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.14516472 |
102 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.14466027 |
103 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13896043 |
104 | Insulin secretion_Homo sapiens_hsa04911 | 0.13516640 |
105 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.13282845 |
106 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.12053982 |
107 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.11958409 |
108 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.11726950 |
109 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.00491199 |
110 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1645720 |
111 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1580617 |
112 | Hepatitis C_Homo sapiens_hsa05160 | -0.1500962 |
113 | Amoebiasis_Homo sapiens_hsa05146 | -0.1475157 |
114 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1462336 |
115 | Malaria_Homo sapiens_hsa05144 | -0.1274118 |
116 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | -0.1271362 |
117 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1255970 |
118 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1246507 |
119 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1179643 |
120 | Legionellosis_Homo sapiens_hsa05134 | -0.1067534 |
121 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1038710 |
122 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0634616 |
123 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0617507 |
124 | Pertussis_Homo sapiens_hsa05133 | -0.0599123 |
125 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0561862 |
126 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0529892 |
127 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0479599 |
128 | Lysosome_Homo sapiens_hsa04142 | -0.0363351 |
129 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0130348 |
130 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0006760 |